173
Participants
Start Date
October 31, 2009
Primary Completion Date
January 31, 2012
Study Completion Date
January 31, 2012
CKD-501 0.5mg
0.5 mg/tablet, orally, 1 tablet once daily for 24 weeks or 52 weeks (If extension study)
Placebo
Indistinguishable tablet from CKD-501, Orally, 1 tablet once daily for 24 weeks
The Inje University Busan-Paik Hospital, Busan
Soon Chun Hyang University Cheonan Hospital, Cheonan
The Hanyang University Medical Center, Gyeonggi-do
Wonju Severance Christian Hospital, Kangwon-Do
The Hallym University Medical Center, Seoul
The Inje University Sanggye-Paik Hospital, Seoul
The Korea University Anam Hospital, Seoul
The Kyung Hee University Medical Center, Seoul
The Seoul National University Bundang Hospital, Seoul
Lead Sponsor
Chong Kun Dang Pharmaceutical
INDUSTRY